Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouquet, Gregory, Marcq, Ingrid, Debuysscher, Véronique, Bayry, Jagadeesh, Rabbind Singh, Amrathlal, Bengrine, Abderrahmane, Nguyen-Khac, Eric, Naassila, Mickael, Bouhlal, Hicham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://www.ncbi.nlm.nih.gov/pubmed/29662641
http://dx.doi.org/10.18632/oncotarget.24575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://www.ncbi.nlm.nih.gov/pubmed/29662641
http://dx.doi.org/10.18632/oncotarget.24575

Ejemplares similares